Recombinant BCGΔBCG1419c protects outbred mice against M. tuberculosis challenge

Area of Science:

• Immunology
• Microbiology
• Vaccinology

Background:

• Mycobacterium tuberculosis poses a significant global health challenge.
• The current Bacille Calmette Guerin (BCG) vaccine has limitations in preventing tuberculosis.
• Development of novel vaccine candidates, including modified BCG strains, is crucial.

Purpose of the Study:

• To evaluate the efficacy of a novel BCG vaccine candidate, BCGΔBCG1419c, in genetically diverse mice.
• To compare the protective potential of BCGΔBCG1419c against Mycobacterium tuberculosis challenge with the parental BCG strain.

Main Methods:

• Utilized Diversity Outbred (DO) mice, a genetically heterogeneous model.
• Administered the novel BCGΔBCG1419c vaccine candidate.
• Assessed protection against Mycobacterium tuberculosis challenge.

Main Results:

• BCGΔBCG1419c demonstrated significant protection against M. tuberculosis.
• Protection afforded by BCGΔBCG1419c was equivalent to or superior to the parental BCG strain in DO mice.
• The study confirmed prior findings of BCGΔBCG1419c attenuation and protection in other models.

Conclusions:

• BCGΔBCG1419c is a promising vaccine candidate for tuberculosis prevention.
• Its efficacy in a heterogeneous mouse model supports further development.
• This modified BCG strain warrants consideration for combating the global tuberculosis pandemic.